LORLATINIB vs LOVAZA: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LORLATINIB vs LOVAZA: Safety Overview
| Metric | LORLATINIB | LOVAZA |
|---|---|---|
| Total FAERS Reports | 5,508 | 303 |
| Deaths Reported | 1,542 | 3 |
| Death Rate | 28.0% | 1.0% |
| Hospitalizations | 1,232 | 22 |
| Average Patient Age | 56.5 yrs | 61.8 yrs |
| % Female Patients | 54.0% | N/A |
| FDA Approval Date | Nov 2, 2018 | N/A |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |